Natalizumab Drug Information

Natalizumab (Tysabri®) is a medication prescribed for the treatment of multiple sclerosis (MS) or Crohn's disease. The medicine is only approved for use in adults age 18 and older. It comes in the form of an intravenous (IV) injection that is administered by a healthcare provider every four weeks. Side effects can include joint pain, depression, and nausea.
 
Specifically, natalizumab can help slow down the worsening of disability and reduce the number of relapses (times when symptoms flare up) in people with MS. It can also help treat and reduce symptoms in people with moderate-to-severe Crohn's disease.
 
Because not everyone should use this drug, your healthcare provider will need certain information from you before prescribing natalizumab. This includes a list of all medications you are taking and any other medical conditions you have, such as a weakened immune system or liver disease.
 
(Click Natalizumab for more information on this drug, including how it works, generic availability, other possible side effects, and more.)
 

Natalizumab Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.